Murat Torğutalp

1.3k total citations
77 papers, 653 citations indexed

About

Murat Torğutalp is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Murat Torğutalp has authored 77 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Rheumatology, 30 papers in Immunology and 13 papers in Hematology. Recurrent topics in Murat Torğutalp's work include Spondyloarthritis Studies and Treatments (39 papers), Rheumatoid Arthritis Research and Therapies (26 papers) and Psoriasis: Treatment and Pathogenesis (23 papers). Murat Torğutalp is often cited by papers focused on Spondyloarthritis Studies and Treatments (39 papers), Rheumatoid Arthritis Research and Therapies (26 papers) and Psoriasis: Treatment and Pathogenesis (23 papers). Murat Torğutalp collaborates with scholars based in Germany, Türkiye and United States. Murat Torğutalp's co-authors include Denis Poddubnyy, Fabian Proft, Valeria Ríos Rodríguez, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Cumali Efe, Joachim Sieper, Taylan Kav and Gülay Kınıklı and has published in prestigious journals such as SHILAP Revista de lepidopterología, Radiology and Annals of the Rheumatic Diseases.

In The Last Decade

Murat Torğutalp

62 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Murat Torğutalp Germany	14	351	189	101	96	88	77	653
Gülşen Özen Türkiye	13	372 1.1×	98 0.5×	51 0.5×	58 0.6×	86 1.0×	31	590
Zeynep Özbalkan Türkiye	16	264 0.8×	216 1.1×	152 1.5×	85 0.9×	66 0.8×	35	792
Ayşe Çefle Türkiye	17	492 1.4×	267 1.4×	92 0.9×	122 1.3×	137 1.6×	94	1.0k
Maria Grazia Anelli Italy	13	303 0.9×	136 0.7×	99 1.0×	45 0.5×	147 1.7×	31	584
Masaaki Nakano Japan	22	419 1.2×	150 0.8×	174 1.7×	184 1.9×	56 0.6×	80	1.0k
Şenol Kobak Türkiye	15	353 1.0×	119 0.6×	92 0.9×	77 0.8×	67 0.8×	88	796
Russell Buchanan Australia	19	432 1.2×	167 0.9×	91 0.9×	111 1.2×	86 1.0×	54	887
Ciprian Jurcuț Romania	14	295 0.8×	146 0.8×	124 1.2×	130 1.4×	40 0.5×	67	649
Francesca Ometto Italy	14	300 0.9×	135 0.7×	45 0.4×	56 0.6×	102 1.2×	29	524
Şule Apraş Bilgen Türkiye	13	239 0.7×	159 0.8×	70 0.7×	94 1.0×	103 1.2×	72	519

Countries citing papers authored by Murat Torğutalp

Since Specialization

Citations

This map shows the geographic impact of Murat Torğutalp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murat Torğutalp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murat Torğutalp more than expected).

Fields of papers citing papers by Murat Torğutalp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murat Torğutalp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murat Torğutalp. The network helps show where Murat Torğutalp may publish in the future.

Co-authorship network of co-authors of Murat Torğutalp

This figure shows the co-authorship network connecting the top 25 collaborators of Murat Torğutalp. A scholar is included among the top collaborators of Murat Torğutalp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murat Torğutalp. Murat Torğutalp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baraliakos, Xenofon, Mikhail Protopopov, Valeria Ríos Rodríguez, et al.. (2025). Radiographic structural damage in axial spondyloarthritis: is there a preferred way to quantify progression over time? Comparison of blinded versus unblinded mSASSS scoring. Annals of the Rheumatic Diseases. 84(8). 1335–1341.

Torğutalp, Murat, et al.. (2025). Similarities and differences: disentangling the intersection between axial psoriatic arthritis and axial spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease. 17. 1759720X251357532–1759720X251357532.

Torğutalp, Murat, Judith Rademacher, Fabian Proft, et al.. (2025). Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy. RMD Open. 11(1). e004921–e004921.

Kiefer, David, Imke Redeker, Murat Torğutalp, et al.. (2025). Longitudinal association of early axial spondyloarthritis status at the time of diagnosis with disease activity over time: 10-year results from the GESPIC cohort. RMD Open. 11(3). e005948–e005948.

Rodríguez, Valeria Ríos, Murat Torğutalp, Fabian Proft, et al.. (2024). Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapy. Lara D. Veeken. 64(3). 1162–1169.

Ziegeler, Katharina, Fabian Proft, Mikhail Protopopov, et al.. (2024). Diagnostic accuracy in axial spondyloarthritis: a systematic evaluation of the role of clinical information in the interpretation of sacroiliac joint imaging. RMD Open. 10(2). e004044–e004044. 6 indexed citations

Rodríguez, Valeria Ríos, Hildrun Haibel, Mikhail Protopopov, et al.. (2024). Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. RMD Open. 10(1). e004009–e004009. 11 indexed citations

Rodríguez, Valeria Ríos, Murat Torğutalp, Clementina López‐Medina, et al.. (2024). Comparing clinical profiles in spondyloarthritis with Crohn’s disease or ulcerative colitis: insights from the ASAS-PerSpA study. Rheumatology Advances in Practice. 8(2). rkae064–rkae064. 3 indexed citations

Troldborg, Anne, Murat Torğutalp, Anne Gitte Loft, et al.. (2024). Complement proteins in axial spondyloarthritis: associations with disease activity and TNFi treatment response in a multicentre RCT. Rheumatology Advances in Practice. 9(1). rkaf007–rkaf007.

10.

Proft, Fabian, Murat Torğutalp, Burkhard Muche, et al.. (2024). Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Annals of the Rheumatic Diseases. 83(5). 599–607. 9 indexed citations

11.

Torğutalp, Murat, Valeria Ríos Rodríguez, Fabian Proft, et al.. (2022). Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis. Annals of the Rheumatic Diseases. 81(9). 1252–1259. 12 indexed citations

12.

Torğutalp, Murat, Valeria Ríos Rodríguez, Fabian Proft, et al.. (2022). The impact of psoriasis on the clinical characteristics, disease burden and treatment patterns of peripheral spondyloarthritis. Lara D. Veeken. 62(1). 135–146. 1 indexed citations

13.

Proft, Fabian, H. Brandt, Gerd R Burmester, et al.. (2022). Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study. RMD Open. 8(2). e002626–e002626. 2 indexed citations

14.

Torğutalp, Murat, Valeria Ríos Rodríguez, Fabian Proft, et al.. (2022). Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time‐Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10‐Year Results From the German Spondyloarthritis Inception Cohort. Arthritis & Rheumatology. 74(9). 1515–1523. 12 indexed citations

15.

Poddubnyy, Denis, Fabian Proft, Laura Spiller, et al.. (2021). Diagnosing axial spondyloarthritis: estimation of the disease probability in patients witha prioridifferent likelihoods of the diagnosis. Lara D. Veeken. 60(11). 5098–5104. 9 indexed citations

16.

Torğutalp, Murat, et al.. (2021). Clinical Features of Patients with Antiphospholipid Syndrome and Differences of Patients with Recurrent Thrombosis, A Single Center Retrospective Study. SHILAP Revista de lepidopterología. 74(1). 52–59.

17.

Torğutalp, Murat, et al.. (2021). Interstitial Lung Disease in Systemic Sclerosis: A Single-center RetrospectiveAnalysis. Current Rheumatology Reviews. 18(2). 150–156. 2 indexed citations

18.

Proft, Fabian, Anja Weiß, Murat Torğutalp, et al.. (2021). Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial. Therapeutic Advances in Musculoskeletal Disease. 13. 1759720X20987700–1759720X20987700. 6 indexed citations

19.

Karahan, Zeynep Ceren, et al.. (2021). High mobility group box- 1 levels may be associated with disease activity of Behcet’s disease. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(5). 2690–2697. 2 indexed citations

20.

Demir, Nurhan, Nazım Ekin, Murat Torğutalp, Staffan Wåhlin, & Cumali Efe. (2020). Two decades of research on autoimmune liver disease in Turkey. The Turkish Journal of Gastroenterology. 31(12). 877–882. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact